A. Nezos

发表

Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.

M. Koutsilieris, M. Crow, E. Kapsogeorgou, 2015, Journal of autoimmunity.

Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome.

A. Tzioufas, S. Gandolfo, L. Quartuccio, 2017, Clinical and experimental rheumatology.

+3179G/A Insulin-Like Growth Factor-1 Receptor Polymorphism: A Novel Susceptibility Contributor in Anti-Ro/SSA Positive Patients with Sjögren’s Syndrome: Potential Clinical and Pathogenetic Implications

M. Koutsilieris, H. Moutsopoulos, C. Mavragani, 2021, Journal of clinical medicine.

B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.

M. Koutsilieris, A. Tzioufas, H. Moutsopoulos, 2014, Journal of autoimmunity.

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis

C. Mavragani, A. Nezos, 2015, Journal of immunology research.

Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.

M. Crow, S. Seshan, C. Mavragani, 2017, Journal of autoimmunity.

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients

M. Koutsilieris, A. Tzioufas, C. Mavragani, 2018, Journal of immunology research.

THU0204 ASSOCIATION OF LILRA3 GENE WITH LYMPHOMAGENESIS RISK IN YOUNG SS PATIENTS

A. Tzioufas, H. Moutsopoulos, C. Mavragani, 2019, Poster Presentations.

TREX1 variants in Sjogren's syndrome related lymphomagenesis.

M. Crow, S. Gandolfo, S. De Vita, 2020, Cytokine.

Long interspersed nuclear element‐1 retroelements are expressed in patients with systemic autoimmune disease and induce type I interferon

M. Crow, S. Seshan, H. Moutsopoulos, 2016 .

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease

M. Crow, S. Seshan, H. Moutsopoulos, 2016, Arthritis & rheumatology.

Detection of circulating tumor cells in bladder cancer using multiplex PCR assays.

M. Koutsilieris, C. Constantinides, K. Stravodimos, 2014, Anticancer research.

Detection of circulating tumor cells in bladder cancer patients.

M. Koutsilieris, A. Nezos, A. Sourla, 2009, Cancer treatment reviews.

Independent association of low IFNλ1 gene expression and type I IFN score/IFNλ1 ratio with obstetric manifestations and triple antiphospholipid antibody positivity in primary antiphospholipid syndrome.

E. Andreakos, M. Tektonidou, C. Mavragani, 2019, Clinical immunology.

B-cell activating factor and related genetic variants in lupus related atherosclerosis.

M. Koutsilieris, H. Moutsopoulos, M. Tektonidou, 2018, Journal of autoimmunity.

Preferential expression of IGF‐1Ec (MGF) transcript in cancerous tissues of human prostate: Evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells

C. Petraki, M. Koutsilieris, A. Nezos, 2010, The Prostate.

Osteoprotegerin and MTHFR gene variations in rheumatoid arthritis: association with disease susceptibility and markers of subclinical atherosclerosis

I. Papadaki, P. Sfikakis, C. Mavragani, 2021, Scientific Reports.

Scleroderma specific autoantibodies and MS-like manifestations: A novel association?

G. Velonakis, C. Mavragani, A. Nezos, 2021, Autoimmunity reviews.

Multiplex PCR-based detection of circulating tumor cells in lung cancer patients using CK19, PTHrP, and LUNX specific primers.

K. Syrigos, M. Koutsilieris, A. Nezos, 2013, Clinical lung cancer.

B-cell Activating Factor Polymorphisms in Rheumatoid Arthritis-Associated Atherosclerosis

C. Mavragani, A. Nezos, E. Theodorou, 2021, Mediterranean journal of rheumatology.

The role of insulin growth factors in autoimmune diseases

M. Koutsilieris, C. Mavragani, A. Nezos, 2019, Annals of Research Hospitals.

Expression of the Insulin-like Growth Factor 1 ( IGF-1 ) and Type I IGF Receptor mRNAs in Human HLEB 3 Lens Epithelial Cells

M. Moschos, M. Koutsilieris, A. Nezos, 2011 .

IGF1Ec expression in MG-63 human osteoblast-like osteosarcoma cells.

M. Koutsilieris, A. Nezos, A. Philippou, 2011, Anticancer Research.

Expression of the insulin-like growth factor 1 (IGF-1) and type I IGF receptor mRNAs in human HLE-B3 lens epithelial cells.

M. Moschos, M. Koutsilieris, A. Nezos, 2011, In vivo.

Detection of the circulating tumor cells in cancer patients.

Michael Koutsilieris, M. Koutsilieris, A. Nezos, 2010, Future oncology.

Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.

H. Moutsopoulos, C. Mavragani, A. Nezos, 2017, Clinical immunology.

The Role of Novel Autoantibodies in the Diagnostic Approach and Prognosis of Patients with Raynaud’s Phenomenon

C. Mavragani, A. Nezos, N. Marketos, 2020, Mediterranean journal of rheumatology.

Association Between DNA Damage Response, Fibrosis and Type I Interferon Signature in Systemic Sclerosis

P. Sfikakis, V. Souliotis, C. Mavragani, 2020, Frontiers in Immunology.

New advances in the classification, pathogenesis and treatment of Sjogren's syndrome

H. Moutsopoulos, C. Mavragani, A. Nezos, 2013, Current opinion in rheumatology.

Milk Fat Globule Epidermal Growth Factor 8 (MFGE8) Gene Variants in Rheumatoid Arthritis and Sjögren’s Syndrome

C. Mavragani, A. Nezos, Charalampos Skarlis, 2022, Journal of clinical medicine.

Molecular and clinical spectrum of four pedigrees of TRAPS in Greece: results from a national referral center.

E. Eliopoulos, P. Karagianni, A. Tzioufas, 2020, Rheumatology.

Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

C. Mavragani, A. Nezos, Charalampos Skarlis, 2022, Frontiers in Pharmacology.

Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.

M. Gazouli, L. Sechi, N. Dovrolis, 2020, Inflammatory bowel diseases.

Genetic contributors and soluble mediators in prediction of autoimmune comorbidity.

C. Mavragani, A. Nezos, M. Evangelopoulos, 2019, Journal of autoimmunity.

THU0228 EXPRESSION OF APOBEC FAMILY MEMBERS AS REGULATORS OF ENDOGENOUS RETROELEMENTS AND MALIGNANCY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND SJÖGREN’S SYNDROME

S. Wahl, M. Crow, S. Seshan, 2019, Poster Presentations.

Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores.

M. Koutsilieris, A. Tzioufas, H. Moutsopoulos, 2016, Clinical immunology.

Etiopathogenesis of Sjogren’s Syndrome

C. Mavragani, A. Nezos, 2016 .

Expression of tissue remodelling, inflammation- and angiogenesis-related factors after eccentric exercise in humans

M. Koutsilieris, M. Maridaki, A. Nezos, 2021, Molecular Biology Reports.

Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren’s Syndrome

A. Tzioufas, H. Moutsopoulos, C. Mavragani, 2021, Journal of clinical medicine.

Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma

G. Panayotou, J. Koskinas, S. Dourakis, 2022, Current issues in molecular biology.

THU0298 Type I Interferon Predicts Biological Effect of Belimumab on Rheumatoid Factor Positive B-Cells in Sjögren's Syndrome: Results from The Beliss Trial

A. Tzioufas, S. Gandolfo, L. Quartuccio, 2016 .

Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance

H. Gogas, M. Koutsilieris, A. Nezos, 2009, Clinical chemistry and laboratory medicine.

Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity.

S. Wahl, M. Crow, S. Seshan, 2020, Clinical immunology.

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome

M. Koutsilieris, A. Saetta, P. Sfikakis, 2017, Scientific Reports.

CD40/CD40L signaling and its implication in health and disease

A. Nezos, E. Kamper, A. Chatzigeorgiou, 2009, BioFactors.

Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.

M. Koutsilieris, A. Nezos, A. Theos, 2012, Oncology reports.

Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus

P. Sfikakis, V. Souliotis, M. Tektonidou, 2021, Clinical Immunology.

Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations

H. Moutsopoulos, C. Mavragani, A. Nezos, 2016, Arthritis care & research.

Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren’s Syndrome-Related Lymphoma?

M. Koutsilieris, A. Tzioufas, H. Moutsopoulos, 2021, Frontiers in Immunology.

Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?

H. Moutsopoulos, C. Mavragani, A. Nezos, 2018, Clinical and experimental rheumatology.

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren’s syndrome

M. Koutsilieris, A. Saetta, P. Sfikakis, 2017, Scientific Reports.

Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.

P. Karagianni, A. Tzioufas, H. Moutsopoulos, 2018, Clinical and experimental rheumatology.